{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:37:06Z","timestamp":1789522626166,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.humpath.2022.12.011","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T20:07:20Z","timestamp":1671480440000},"page":"85-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Loss of dystrophin is common in uterine leiomyosarcoma: a potential biomarker for clinical application"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2062-7671","authenticated-orcid":false,"given":"Brian","family":"Vadasz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Felicelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Bulun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.12.011_bib1","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1002\/cncr.28900","article-title":"Molecular analyses of 6 different types of uterine smooth muscle tumors: emphasis in atypical leiomyoma","volume":"120","author":"Zhang","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2022.12.011_bib2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/0002-9378(90)91298-Q","article-title":"Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas","volume":"162","author":"Leibsohn","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.humpath.2022.12.011_bib3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0090-8258(03)00137-9","article-title":"Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy","volume":"89","author":"Giuntoli","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2022.12.011_bib4","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/cncr.2820710440","article-title":"Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study","volume":"71","author":"Major","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2022.12.011_bib5","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s41379-022-01011-z","article-title":"A novel morphology-based risk stratification model for stage I uterine leiomyosarcoma: an analysis of 203 cases","volume":"35","author":"Chapel","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.12.011_bib6","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/cas.14775","article-title":"Integrated histologic and molecular analysis of uterine leiomyosarcoma and 2 benign variants with nuclear atypia","volume":"112","author":"Gao","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.humpath.2022.12.011_bib7","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1038\/s41467-021-24677-6","article-title":"Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival","volume":"12","author":"Anderson","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2022.12.011_bib8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","article-title":"Dystrophin and mutations: one gene, several proteins, multiple phenotypes","volume":"2","author":"Muntoni","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.humpath.2022.12.011_bib9","first-page":"1144","article-title":"MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma","volume":"27","author":"Bertsch","year":"2014","journal-title":"Mod Pathol Off J US Can Acad Pathol Inc"},{"key":"10.1016\/j.humpath.2022.12.011_bib10","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2. 0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"key":"10.1016\/j.humpath.2022.12.011_bib11","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3390\/genes10090678","article-title":"Focal recurrent copy number alterations characterize disease relapse in high grade serous ovarian cancer patients with good clinical prognosis: a pilot study","volume":"10","author":"Dugo","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.humpath.2022.12.011_bib12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2559.2009.03231.x","article-title":"Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients","volume":"54","author":"Abeler","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.12.011_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/IGC.0b013e3181c9e289","article-title":"Metastatic uterine leiomyosarcomas: a single-institution experience","volume":"20","author":"Bernstein-Molho","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.humpath.2022.12.011_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","article-title":"Bone Sarcoma G: doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial","volume":"15","author":"Judson","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2022.12.011_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12943-017-0672-1","article-title":"Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors","volume":"16","author":"Makinen","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1016\/j.humpath.2022.12.011_bib16","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/modpathol.2013.243","article-title":"MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma","volume":"27","author":"Bertsch","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.12.011_bib17","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/bjc.2012.428","article-title":"Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer","volume":"107","author":"Kampjarvi","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2022.12.011_bib18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/modpathol.2012.203","article-title":"MED12 mutations in leiomyosarcoma and extrauterine leiomyoma","volume":"26","author":"Ravegnini","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.12.011_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41467-017-02602-0","article-title":"Integrative genomic and transcriptomic analysis of leiomyosarcoma","volume":"9","author":"Chudasama","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2022.12.011_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cancergencyto.2005.01.011","article-title":"Loss of DNA copy number of 10q is associated with aggressive behavior of leiomyosarcomas: a comparative genomic hybridization study","volume":"161","author":"Hu","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.humpath.2022.12.011_bib21","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00432-012-1182-6","article-title":"Analysis of molecular cytogenetic alterations in uterine leiomyosarcoma by array-based comparative genomic hybridization","volume":"138","author":"Raish","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.humpath.2022.12.011_bib22","first-page":"118","article-title":"Integrated mutational landscape analysis of uterine leiomyosarcomas","author":"Choi","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2022.12.011_bib23","article-title":"Identification of somatic genetic alterations using whole-exome sequencing of uterine leiomyosarcoma tumors","volume":"11","author":"Chen","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2022.12.011_bib24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/onc.2009.381","article-title":"Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling","volume":"29","author":"Beck","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2022.12.011_bib25","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1158\/1078-0432.CCR-14-3141","article-title":"Clinically relevant molecular subtypes in leiomyosarcoma","volume":"21","author":"Guo","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2022.12.011_bib26","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cell.2017.10.014","article-title":"Electronic address edsc, cancer genome atlas research N: comprehensive and integrated genomic characterization of adult soft tissue sarcomas","volume":"171","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2022.12.011_bib27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/ng.2974","article-title":"Dystrophin is a tumor suppressor in human cancers with myogenic programs","volume":"46","author":"Wang","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2022.12.011_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.18632\/oncotarget.10426","article-title":"Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations","volume":"8","author":"Luce","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2022.12.011_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2045-3329-4-9","article-title":"Dystrophin deregulation is associated with tumor progression in KIT\/PDGFRA mutant gastrointestinal stromal tumors","volume":"4","author":"Pantaleo","year":"2014","journal-title":"Clin Sarcoma Res"},{"key":"10.1016\/j.humpath.2022.12.011_bib30","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0092-8674(91)90035-W","article-title":"Membrane organization of the dystrophin-glycoprotein complex","volume":"66","author":"Ervasti","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2022.12.011_bib31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2022.12.011_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrm3141","article-title":"The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function","volume":"12","author":"Murphy","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.humpath.2022.12.011_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/PAP.0b013e3181cfb901","article-title":"Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy","volume":"17","author":"Ip","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2022.12.011_bib34","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/PAS.0b013e3181a02d1c","article-title":"Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases","volume":"33","author":"Ip","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.12.011_bib35","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ygyno.2009.02.020","article-title":"Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis","volume":"113","author":"Guntupalli","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2022.12.011_bib36","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/PAS.0b013e318287779c","article-title":"Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma: immunohistochemical study of 68 cases with clinical follow-up","volume":"37","author":"Mills","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.12.011_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040015","article-title":"MED12 alterations in both human benign and malignant uterine soft tissue tumors","volume":"7","author":"Perot","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2022.12.011_bib38","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/modpathol.2016.107","article-title":"Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors","volume":"29","author":"Liegl-Atzwanger","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.12.011_bib39","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/modpathol.2017.56","article-title":"Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases","volume":"30","author":"Bennett","year":"2017","journal-title":"Mod Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722002891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722002891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:41:02Z","timestamp":1758645662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722002891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":39,"alternative-id":["S0046817722002891"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.12.011","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of dystrophin is common in uterine leiomyosarcoma: a potential biomarker for clinical application","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}